TY - JOUR AU - Auperin, A. AU - Pechoux, C. AU - Rolland, E. AU - Curran, W. J. AU - Furuse, K. AU - Fournel, P. PY - 2010 DA - 2010// TI - Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.2543 DO - 10.1200/JCO.2009.26.2543 ID - Auperin2010 ER - TY - JOUR AU - Ahn, J. S. AU - Ahn, Y. C. AU - Kim, J. H. AU - Lee, C. G. AU - Cho, E. K. AU - Lee, K. C. PY - 2015 DA - 2015// TI - Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent Chemoradiation in inoperable stage III non-small-cell lung Cancer: KCSG-LU05-04 JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.60.0130 DO - 10.1200/JCO.2014.60.0130 ID - Ahn2015 ER - TY - JOUR AU - Antonia, S. J. AU - Villegas, A. AU - Daniel, D. AU - Daniel, D. AU - Vicente, D. AU - Murakami, S. PY - 2017 DA - 2017// TI - Durvalumab after Chemoradiotherapy in stage III non-small-cell lung Cancer JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1709937 DO - 10.1056/NEJMoa1709937 ID - Antonia2017 ER - TY - JOUR AU - Bradley, J. D. AU - Paulus, R. AU - Komaki, R. AU - Masters, G. AU - Blumenschein, G. AU - Schild, S. PY - 2015 DA - 2015// TI - Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(14)71207-0 DO - 10.1016/S1470-2045(14)71207-0 ID - Bradley2015 ER - TY - JOUR AU - Osti, M. F. AU - Agolli, L. AU - Valeriani, M. AU - Falco, T. AU - Bracci, S. AU - Sanctis, V. PY - 2013 DA - 2013// TI - Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer JO - Int J Radiat Oncol Biol Phys VL - 85 UR - https://doi.org/10.1016/j.ijrobp.2012.10.012 DO - 10.1016/j.ijrobp.2012.10.012 ID - Osti2013 ER - TY - JOUR AU - Kaster, T. S. AU - Yaremko, B. AU - Palma, D. A. AU - Rodrigues, G. B. PY - 2015 DA - 2015// TI - Radical-intent hypofractionated radiotherapy for locally advanced non-small-cell lung cancer: a systematic review of the literature JO - Clin Lung Cancer VL - 16 UR - https://doi.org/10.1016/j.cllc.2014.08.002 DO - 10.1016/j.cllc.2014.08.002 ID - Kaster2015 ER - TY - JOUR AU - Cannon, D. M. AU - Mehta, M. P. AU - Adkison, J. B. AU - Khuntia, D. AU - Traynor, A. M. AU - Tomé, W. A. PY - 2013 DA - 2013// TI - Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.51.5353 DO - 10.1200/JCO.2013.51.5353 ID - Cannon2013 ER - TY - JOUR AU - He, J. AU - Huang, Y. AU - Chen, Y. AU - Shi, S. AU - Ye, L. AU - Hu, Y. PY - 2016 DA - 2016// TI - Feasibility and efficacy of helical intensity-modulated radiotherapy for stage III non-small cell lung cancer in comparison with conventionally fractionated 3D-CRT JO - J Thorac Dis VL - 8 UR - https://doi.org/10.21037/jtd.2016.03.46 DO - 10.21037/jtd.2016.03.46 ID - He2016 ER - TY - JOUR AU - Liu, Y. E. AU - Lin, Q. AU - Meng, F. J. AU - Chen, X. J. AU - Ren, X. C. AU - Cao, B. PY - 2013 DA - 2013// TI - High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study JO - Radiat Oncol VL - 8 UR - https://doi.org/10.1186/1748-717X-8-198 DO - 10.1186/1748-717X-8-198 ID - Liu2013 ER - TY - JOUR AU - Denkert, C. AU - Minckwitz, G. AU - Brase, J. C. AU - Sinn, B. V. AU - Gade, S. AU - Kronenwett, R. PY - 2015 DA - 2015// TI - Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.1967 DO - 10.1200/JCO.2014.58.1967 ID - Denkert2015 ER - TY - JOUR AU - Fang, P. AU - Jiang, W. AU - Davuluri, R. AU - Xu, C. AU - Krishnan, S. AU - Mohan, R. PY - 2018 DA - 2018// TI - High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer JO - Radiother Oncol VL - 128 UR - https://doi.org/10.1016/j.radonc.2018.02.025 DO - 10.1016/j.radonc.2018.02.025 ID - Fang2018 ER - TY - JOUR AU - Wu, E. S. AU - Oduyebo, T. AU - Cobb, L. P. AU - Cholakian, D. AU - Kong, X. AU - Fader, A. N. PY - 2016 DA - 2016// TI - Lymphopenia and its association with survival in patients with locally advanced cervical cancer JO - Gynecol Oncol VL - 140 UR - https://doi.org/10.1016/j.ygyno.2015.11.013 DO - 10.1016/j.ygyno.2015.11.013 ID - Wu2016 ER - TY - JOUR AU - Grossman, S. A. AU - Ellsworth, S. AU - Campian, J. AU - Wild, A. T. AU - Herman, J. M. AU - Laheru, D. PY - 2015 DA - 2015// TI - Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors JO - J Natl Compr Cancer Netw VL - 13 UR - https://doi.org/10.6004/jnccn.2015.0151 DO - 10.6004/jnccn.2015.0151 ID - Grossman2015 ER - TY - JOUR AU - Venkatesulu, B. P. AU - Mallick, S. AU - Lin, S. H. AU - Krishnan, S. PY - 2018 DA - 2018// TI - A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors JO - Crit Rev Oncol Hematol VL - 123 UR - https://doi.org/10.1016/j.critrevonc.2018.01.003 DO - 10.1016/j.critrevonc.2018.01.003 ID - Venkatesulu2018 ER - TY - JOUR AU - Tang, C. AU - Liao, Z. AU - Gomez, D. AU - Levy, L. AU - Zhuang, Y. AU - Gebremichael, R. A. PY - 2014 DA - 2014// TI - Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes JO - Int J Radiat Oncol Biol Phys VL - 89 UR - https://doi.org/10.1016/j.ijrobp.2014.04.025 DO - 10.1016/j.ijrobp.2014.04.025 ID - Tang2014 ER - TY - JOUR AU - Yovino, S. AU - Kleinberg, L. AU - Grossman, S. A. AU - Narayanan, M. AU - Ford, E. PY - 2013 DA - 2013// TI - The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells JO - Cancer Investig VL - 31 UR - https://doi.org/10.3109/07357907.2012.762780 DO - 10.3109/07357907.2012.762780 ID - Yovino2013 ER - TY - JOUR AU - Fowler, J. F. PY - 2010 DA - 2010// TI - 21 years of biologically effective dose JO - Br J Radiol VL - 83 UR - https://doi.org/10.1259/bjr/31372149 DO - 10.1259/bjr/31372149 ID - Fowler2010 ER - TY - JOUR AU - Wild, A. T. AU - Herman, J. M. AU - Dholakia, A. S. AU - Moningi, S. AU - Lu, Y. AU - Rosati, L. M. PY - 2016 DA - 2016// TI - Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with Unresectable pancreatic Cancer JO - Int J Radiat Oncol Biol Phys VL - 94 UR - https://doi.org/10.1016/j.ijrobp.2015.11.026 DO - 10.1016/j.ijrobp.2015.11.026 ID - Wild2016 ER - TY - JOUR AU - Stone, H. B. AU - Peters, L. J. AU - Milas, L. PY - 1979 DA - 1979// TI - Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma JO - J Natl Cancer Inst VL - 63 ID - Stone1979 ER - TY - JOUR AU - Lugade, A. A. AU - Moran, J. P. AU - Gerber, S. A. AU - Rose, R. C. AU - Frelinger, J. G. AU - Lord, E. M. PY - 2005 DA - 2005// TI - Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.12.7516 DO - 10.4049/jimmunol.174.12.7516 ID - Lugade2005 ER - TY - JOUR AU - Lee, Y. AU - Auh, S. L. AU - Wang, Y. AU - Burnette, B. AU - Wang, Y. AU - Meng, Y. PY - 2009 DA - 2009// TI - Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-02-206870 DO - 10.1182/blood-2009-02-206870 ID - Lee2009 ER - TY - JOUR AU - Apetoh, L. AU - Ghiringhelli, F. AU - Tesniere, A. AU - Obeid, M. AU - Ortiz, C. AU - Criollo, A. PY - 2007 DA - 2007// TI - Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1622 DO - 10.1038/nm1622 ID - Apetoh2007 ER - TY - JOUR AU - Loi, S. AU - Sirtaine, N. AU - Piette, F. AU - Salgado, R. AU - Viale, G. AU - Eenoo, F. PY - 2013 DA - 2013// TI - Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98 JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2011.41.0902 DO - 10.1200/JCO.2011.41.0902 ID - Loi2013 ER - TY - JOUR AU - Zhang, L. AU - Conejo-Garcia, J. R. AU - Katsaros, D. AU - Gimotty, P. A. AU - Massobrio, M. AU - Regnani, G. PY - 2003 DA - 2003// TI - Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa020177 DO - 10.1056/NEJMoa020177 ID - Zhang2003 ER - TY - JOUR AU - Pike, L. R. G. AU - Bang, A. AU - Mahal, B. A. AU - Taylor, A. AU - Krishnan, M. AU - Spektor, A. PY - 2019 DA - 2019// TI - The impact of radiation therapy on lymphocyte count and survival in metastatic Cancer patients receiving PD-1 immune checkpoint inhibitors JO - Int J Radiat Oncol Biol Phys VL - 103 UR - https://doi.org/10.1016/j.ijrobp.2018.09.010 DO - 10.1016/j.ijrobp.2018.09.010 ID - Pike2019 ER - TY - JOUR AU - Schreiber, R. D. AU - Old, L. J. AU - Smyth, M. J. PY - 2011 DA - 2011// TI - Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion JO - Science VL - 331 UR - https://doi.org/10.1126/science.1203486 DO - 10.1126/science.1203486 ID - Schreiber2011 ER - TY - JOUR AU - Ku, G. Y. AU - Yuan, J. AU - Page, D. B. AU - Schroeder, S. E. AU - Panageas, K. S. AU - Carvajal, R. D. PY - 2010 DA - 2010// TI - Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24951 DO - 10.1002/cncr.24951 ID - Ku2010 ER - TY - JOUR AU - MacLennan, I. C. AU - Kay, H. E. PY - 1978 DA - 1978// TI - Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation JO - Cancer VL - 41 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - MacLennan1978 ER - TY - JOUR AU - Meyer, K. K. PY - 1970 DA - 1970// TI - Radiation-induced lymphocyte-immune deficiency. A factor in the increased visceral metastases and decreased hormonal responsiveness of breast cancer JO - Arch Surg VL - 101 UR - https://doi.org/10.1001/archsurg.1970.01340260018003 DO - 10.1001/archsurg.1970.01340260018003 ID - Meyer1970 ER - TY - JOUR AU - Sellins, K. S. AU - Cohen, J. J. PY - 1987 DA - 1987// TI - Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes JO - J Immunol VL - 139 ID - Sellins1987 ER - TY - JOUR AU - Yu, H. AU - Qu, Y. AU - Shang, Q. AU - Yan, C. AU - Jiang, P. AU - Wang, X. PY - 2016 DA - 2016// TI - The clinical effects of low-dose splenic irradiation combined with chest three-dimensional conformal radiotherapy on patients with locally advanced non-small-cell lung cancer: a randomized clinical trial JO - Onco Targets Ther VL - 9 UR - https://doi.org/10.2147/OTT.S95992 DO - 10.2147/OTT.S95992 ID - Yu2016 ER - TY - JOUR AU - Hashimoto, S. AU - Shirato, H. AU - Hosokawa, M. AU - Nishioka, T. AU - Kuramitsu, Y. AU - Matushita, K. PY - 1999 DA - 1999// TI - The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats JO - Radiat Res VL - 151 UR - https://doi.org/10.2307/3580211 DO - 10.2307/3580211 ID - Hashimoto1999 ER - TY - JOUR AU - Basler, L. AU - Andratschke, N. AU - Ehrbar, S. AU - Guckenberger, M. AU - Tanadini-Lang, S. PY - 2018 DA - 2018// TI - Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study JO - Radiat Oncol VL - 13 UR - https://doi.org/10.1186/s13014-018-0952-y DO - 10.1186/s13014-018-0952-y ID - Basler2018 ER - TY - JOUR AU - Crocenzi, T. AU - Cottam, B. AU - Newell, P. AU - Wolf, R. F. AU - Hansen, P. D. AU - Hammill, C. PY - 2016 DA - 2016// TI - A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma JO - J Immunother Cancer VL - 4 UR - https://doi.org/10.1186/s40425-016-0149-6 DO - 10.1186/s40425-016-0149-6 ID - Crocenzi2016 ER - TY - JOUR AU - Campian, J. L. AU - Ye, X. AU - Brock, M. AU - Grossman, S. A. PY - 2013 DA - 2013// TI - Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer JO - Cancer Investig VL - 31 UR - https://doi.org/10.3109/07357907.2013.767342 DO - 10.3109/07357907.2013.767342 ID - Campian2013 ER - TY - JOUR AU - Uemura, T. AU - Hida, T. PY - 2018 DA - 2018// TI - Durvalumab showed long and durable effects after chemoradiotherapy in stage III non-small cell lung cancer: results of the PACIFIC study JO - J Thorac Dis VL - 10 UR - https://doi.org/10.21037/jtd.2018.03.180 DO - 10.21037/jtd.2018.03.180 ID - Uemura2018 ER - TY - JOUR AU - Scott, S. C. AU - Pennell, N. A. PY - 2018 DA - 2018// TI - Early use of systemic corticosteroids in patients with advanced NSCLC treated with Nivolumab JO - J Thorac Oncol VL - 13 UR - https://doi.org/10.1016/j.jtho.2018.06.004 DO - 10.1016/j.jtho.2018.06.004 ID - Scott2018 ER - TY - JOUR AU - Brahmer, J. AU - Reckamp, K. L. AU - Baas, P. AU - Crinò, L. AU - Eberhardt, W. E. AU - Poddubskaya, E. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung Cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504627 DO - 10.1056/NEJMoa1504627 ID - Brahmer2015 ER -